Your browser doesn't support javascript.
loading
Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers.
Campbell, Marcia R; Ruiz-Saenz, Ana; Peterson, Elliott; Agnew, Christopher; Ayaz, Pelin; Garfinkle, Sam; Littlefield, Peter; Steri, Veronica; Oeffinger, Julie; Sampang, Maryjo; Shan, Yibing; Shaw, David E; Jura, Natalia; Moasser, Mark M.
Afiliação
  • Campbell MR; Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Ruiz-Saenz A; Departments of Cell Biology & Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Peterson E; Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Agnew C; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Ayaz P; D. E. Shaw Research, New York, NY 10036, USA.
  • Garfinkle S; D. E. Shaw Research, New York, NY 10036, USA.
  • Littlefield P; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Steri V; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Oeffinger J; Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Sampang M; Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Shan Y; D. E. Shaw Research, New York, NY 10036, USA.
  • Shaw DE; D. E. Shaw Research, New York, NY 10036, USA; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA.
  • Jura N; Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Moasser MM; Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA. Electronic address: mark.moasser@ucsf.edu.
Cell Rep ; 38(5): 110291, 2022 02 01.
Article em En | MEDLINE | ID: mdl-35108525
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Receptor ErbB-3 / Carcinogênese Limite: Female / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Receptor ErbB-3 / Carcinogênese Limite: Female / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos